Chris WeiserAssociate General Counsel, Value & Access and Pricing at TevaSpeaker
Agenda Sessions
Acquisition Impact on State Reporting Obligations
, 10:45amView SessionBiosimilars and Generics in 2026: Market Access and Profitability Strategies
, 11:30amView Session
